source
- Claret says it latest fund will have larger focus on European life sciencesEuropean firm Claret Capital Partners has raised €575 million in its latest round, dubbed Fund IV, and a sizable portion will be lent out to local biotech companies and manufacturers. Roughly one t…Endpoints · 20m ago↗ source
- Novartis pauses CAR-T trials after three patient deathsNovartis announced a pause on its experimental CAR-T therapy after three patients died while receiving the treatment. The company said it will halt ongoing immunology and neuroscience studies relat…